AbCellera
expand capabilities against difficult to drug targets with acquisition of and ion channel proteins are high value difficult to drug targets | AbCellera
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
8 of 20
Related slides by other companies
Jefferies Financial Group
Investor Day
October 2022
strategic focus | Jefferies Financial Group
Bakkt
Results
November 2022
apex complements our existing platform apex will enhance some of our current capabilities acquisition provides opportunity to further scale our business a | Bakkt
Quhuo
IPO
July 2020
capability to expand service scope a sustainable value propositions to workers | Quhuo
Elms
SPAC
February 2021
elms agile manufacturing strategy elms believes its strategy will enable it to provide low cost at an accelerated goo | Elms
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io